PAPER Yang J, Fu Z, Zhang X, Xiong M, Meng L, Zhang Z

TREM2 ectodomain and its soluble form in Alzheimer's disease.

J Neuroinflammation. 2020 Jul 7;17(1):204. PubMed: 32635934

PAPER Schepici G, Silvestro S, Bramanti P, Mazzon E

Caffeine: An Overview of Its Beneficial Effects in Experimental Models and Clinical Trials of Parkinson's Disease.

Int J Mol Sci. 2020 Jul 4;21(13) PubMed: 32635541

PAPER Davda N, Corkill R

Biomarkers in the diagnosis and prognosis of Alzheimer's disease.

J Neurol. 2020 Aug;267(8):2475-2477. PubMed: 32638106

PAPER Mueller C, Berry JD, McKenna-Yasek DM, Gernoux G, Owegi MA, Pothier LM, Douthwright CL, Gelevski D, Luppino SD, Blackwood M, Wightman NS, Oakley DH, Frosch MP, Flotte TR, Cudkowicz ME, Brown RH Jr

SOD1 Suppression with Adeno-Associated Virus and MicroRNA in Familial ALS.

N Engl J Med. 2020 Jul 9;383(2):151-158. PubMed: 32640133

PAPER Miller T, Cudkowicz M, Shaw PJ, Andersen PM, Atassi N, Bucelli RC, Genge A, Glass J, Ladha S, Ludolph AL, Maragakis NJ, McDermott CJ, Pestronk A, Ravits J, Salachas F, Trudell R, Van Damme P, Zinman L, Bennett CF, Lane R, Sandrock A, Runz H, Graham D, Houshyar H, McCampbell A, Nestorov I, Chang I, McNeill M, Fanning L, Fradette S, Ferguson TA

Phase 1-2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.

N Engl J Med. 2020 Jul 9;383(2):109-119. PubMed: 32640130

PAPER Rusilowicz-Jones EV, Jardine J, Kallinos A, Pinto-Fernandez A, Guenther F, Giurrandino M, Barone FG, McCarron K, Burke CJ, Murad A, Martinez A, Marcassa E, Gersch M, Buckmelter AJ, Kayser-Bricker KJ, Lamoliatte F, Gajbhiye A, Davis S, Scott HC, Murphy E, England K, Mortiboys H, Komander D, Trost M, Kessler BM, Ioannidis S, Ahlijanian MK, Urbé S, Clague MJ

USP30 sets a trigger threshold for PINK1-PARKIN amplification of mitochondrial ubiquitylation.

Life Sci Alliance. 2020 Aug;3(8) Print 2020 Aug PubMed: 32636217

PAPER Hernández-Rodríguez M, Arciniega-Martínez IM, García-Marín ID, Correa-Basurto J, Rosales-Hernández MC

Chronic Administration of Scopolamine Increased GSK3βP9, Beta Secretase, Amyloid Beta, and Oxidative Stress in the Hippocampus of Wistar Rats.

Mol Neurobiol. 2020 Sep;57(9):3979-3988. Epub 2020 Jul 7 PubMed: 32638218

Deep Tissue Imaging Request for Applications (RFA)

GRANT Thursday, July 9, 2020- 15:30 Chan Zuckerberg Initiative $1 million in total over 2.5 years for each pilot project, and successful pilots will be eligible to apply for additional four-year follow.s August 6, 2020, by 5 p.m. Pacific Time Deep Tissue ...

Keira Panozzo

Ben Whitlock

Brain Barriers Virtual (BBV) 2020: "Circadian-mediated cycling of claudin-5 in health and disease"

CONFERENCE 2020-07-15 00:00:00-2020-07-15 00:00:00 Online Meeting 15 July 2020 Organizers: Bjoern Bauer, University of Kentucky, Anika Hartz, University of Kentucky, Brandon Kim, University of Wisconsin, Madison Speaker: Matthew Campbell, PhD, Trinity College Dublin Meeting time: 12 PM EDT To sign-up: ...

Postdoctoral Research Scholar, Edson Foundation

JOB 2020-07-09 Employer ASU-Banner Neurodegenerative Disease Research Center at Arizona State University Principal Investigator Ben Readhead Contact Application Instructions: Applicants are responsible for including a cover letter, CV, and the names of three ...

Postdoctoral Scientist

JOB 2020-07-09 Employer Columbia University Irving Medical Center Principal Investigator Abid Hussaini Contact sah2149@columbia.edu Description The Taub Institute for Research on Alzheimer’s disease and the Aging Brain is seeking a Postdoctoral Scientist to join the ...

Elizabeth Andrews

University of California, Irvine
Irvine, United States

Shahram Oveisgharan on Women and Men Differ in Their Genetic Risk for Alzheimer’s Progression

COMMENT C.C. Fan et al. developed and examined a sex-stratified polygenic score for prediction of AD age of onset and other AD phenotypes, including AD pathological hallmarks. Their study expands recently published GWAS papers, exploring genes that were ...